Miranda Cooper

Head of Statistics, HEOR

Miranda joined the company in 2014, when the company was known as BresMed, having completed a master’s degree in statistics from the University of Sheffield and a bachelor’s degree in mathematics from the University of Durham.

Miranda has led the development of statistical analyses to support health technology assessment (HTA) submissions and as part of standalone research. She has experience in using a range of statistical methods, such as patient level data analysis, parametric survival analysis, population adjustment techniques, crossover analysis, utility analysis, and indirect treatment comparisons, including approaches that allow time-varying treatment effects.

Miranda also has experience in a range of indications – both oncology based, including melanoma, multiple myeloma, non-Hodgkin lymphoma and renal cell carcinoma – and non-oncology based, such as postpartum depression, psoriasis, and epilepsy.